Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 1

Interventions

telapristone acetate 13estradiol, norethindrone drug combination 9elagolix 7Estradiol 7relugolix 6Norethindrone Acetate 5vilaprisan 4ulipristal acetate 4Sugars 3Uterine Myomectomy 2Lidocaine 2Leuprolide 2Letrozole 2ulipristal 1epigallocatechin gallate 1Vitamin B 6 1Uterine Artery Embolization 1Tranexamic Acid 1Therapeutics 1Standard of Care 1Sodium Chloride 1Ropivacaine 1Rocuronium 1Progesterone 1Pregabalin 1Morphine 1Misoprostol 1Mifepristone 1Injections, Subcutaneous 1Ibuprofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leiomyoma × ulipristal × Clear all
NCT00290251 2024-07-15

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
72 enrolled 7 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡